[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Homeyer et al., 2014 - Google Patents

Binding free energy calculations for lead optimization: assessment of their accuracy in an industrial drug design context

Homeyer et al., 2014

View PDF
Document ID
1392003021768690087
Author
Homeyer N
Stoll F
Hillisch A
Gohlke H
Publication year
Publication venue
Journal of chemical theory and computation

External Links

Snippet

Correctly ranking compounds according to their computed relative binding affinities will be of great value for decision making in the lead optimization phase of industrial drug discovery. However, the performance of existing computationally demanding binding free energy …
Continue reading at cpclab.uni-duesseldorf.de (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/50—Computer-aided design
    • G06F17/5009—Computer-aided design using simulation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F11/00—Error detection; Error correction; Monitoring

Similar Documents

Publication Publication Date Title
Homeyer et al. Binding free energy calculations for lead optimization: assessment of their accuracy in an industrial drug design context
Song et al. Using AMBER18 for relative free energy calculations
Cole et al. Biomolecular force field parameterization via atoms-in-molecule electron density partitioning
Roos et al. OPLS3e: Extending force field coverage for drug-like small molecules
Wang et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field
Doerr et al. HTMD: high-throughput molecular dynamics for molecular discovery
Hamelberg et al. Standard free energy of releasing a localized water molecule from the binding pockets of proteins: double-decoupling method
Zou et al. Inclusion of solvation in ligand binding free energy calculations using the generalized-born model
Huang et al. Automated force field parameterization for nonpolarizable and polarizable atomic models based on ab initio target data
Carlsson et al. Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase
Kolar et al. Assessing the accuracy and performance of implicit solvent models for drug molecules: conformational ensemble approaches
Sulea et al. Solvated interaction energy (SIE) for scoring protein–ligand binding affinities. 2. Benchmark in the CSAR-2010 scoring exercise
Thapa et al. Theoretical study of protein–ligand interactions using the molecules-in-molecules fragmentation-based method
Ellis et al. Constant pH molecular dynamics reveals pH-modulated binding of two small-molecule BACE1 inhibitors
Layfield et al. Calculation of vibrational shifts of nitrile probes in the active site of ketosteroid isomerase upon ligand binding
Razavi et al. Computational screening and selection of cyclic peptide hairpin mimetics by molecular simulation and kinetic network models
Kumar et al. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening
Wahl et al. Assessing the predictive power of relative binding free energy calculations for test cases involving displacement of binding site water molecules
Liu et al. Improving the scoring of protein–ligand binding affinity by including the effects of structural water and electronic polarization
Bhati et al. Large scale study of ligand–protein relative binding free energy calculations: actionable predictions from statistically robust protocols
Egidi et al. The electronic circular dichroism of nicotine in aqueous solution: a test case for continuum and mixed explicit-continuum solvation approaches
Evans et al. Combining machine learning and enhanced sampling techniques for efficient and accurate calculation of absolute binding free energies
Calabrò et al. Elucidation of nonadditive effects in protein–ligand binding energies: Thrombin as a case study
Wang et al. Host–guest relative binding affinities at density-functional theory level from semiempirical molecular dynamics simulations
Cui et al. Unraveling the allosteric inhibition mechanism of PTP1B by free energy calculation based on umbrella sampling